Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model

Traumatic brain injury (TBI) causes both physical disruption of the blood brain barrier (BBB) and altered immune responses that can lead to significant secondary brain injury and chronic inflammation within the central nervous system (CNS). Cell therapies, including mesenchymal stromal cells (MSC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Caplan, Henry W., Prabhakara, Karthik S., Toledano Furman, Naama E., Zorofchian, Soheil, Martin, Cecilia, Xue, Hasen, Olson, Scott D., Cox, Charles S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153465/
https://www.ncbi.nlm.nih.gov/pubmed/34038436
http://dx.doi.org/10.1371/journal.pone.0251601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153465/
https://www.ncbi.nlm.nih.gov/pubmed/34038436
http://dx.doi.org/10.1371/journal.pone.0251601

Ejemplares similares